Mindray Medical International (MR) Tops Q2 EPS by 5c; Reaffirms non-GAAP Views
Tweet Send to a FriendGet Alerts MR Hot Sheet
Trade MR Now!
Mindray Medical International (NYSE: MR) reported Q2 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $267.8 million versus the consensus estimate of $258.7 million.
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Mindray Medical International reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
